Effect of combined therapy with cytosine arabinoside (NSC-63878) and l,3-bis-(2-chloroethyl)-1-nitrosourea (NSC-409962) on sarcoma 180 and L1210 in vivo.
D000818:Animals; D003561:Cytarabine / Q000627:therapeutic use*; D004273:DNA, Neoplasm / Q000096:biosynthesis; D004357:Drug Synergism; D005260:Female; D007939:Leukemia L1210 / Q000188:drug therapy; D051379:Mice; D009374:Neoplasms, Experimental / Q000188:drug therapy*; D009603:Nitroso Compounds / Q000627:therapeutic use*; D012513:Sarcoma, Experimental / Q000188:drug therapy; D013936:Thymidine / Q000378:metabolism; D013997:Time Factors; D014316:Tritium; D014508:Urea / Q000627:therapeutic use
D004273:DNA, Neoplasm; D009603:Nitroso Compounds; D003561:Cytarabine; D014316:Tritium; D014508:Urea; D013936:Thymidine